{"id":"https://openalex.org/W4282914532","doi":"https://doi.org/10.1158/1538-7445.am2022-ct123","title":"Abstract CT123: A phase 2 study of the MDM2 inhibitor milademetan in patients with TP53-wild type and MDM2-amplified advanced or metastatic solid tumors (MANTRA-2)","display_name":"Abstract CT123: A phase 2 study of the MDM2 inhibitor milademetan in patients with TP53-wild type and MDM2-amplified advanced or metastatic solid tumors (MANTRA-2)","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282914532","doi":"https://doi.org/10.1158/1538-7445.am2022-ct123"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-ct123","doi":"https://doi.org/10.1158/1538-7445.am2022-ct123","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-ct123","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103984818","display_name":"Ecaterina Ileana Dumbrava","orcid":"https://orcid.org/0000-0002-1959-0536","observed_orcids":["https://orcid.org/0000-0002-1959-0536"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ecaterina I. Dumbrava","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036875036","display_name":"Glenn J. Hanna","orcid":"https://orcid.org/0000-0002-9969-2523","observed_orcids":["https://orcid.org/0000-0002-9969-2523"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glenn J. Hanna","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105923745","display_name":"Gregory Michael Cote","orcid":"https://orcid.org/0000-0003-0181-886X","observed_orcids":["https://orcid.org/0000-0003-0181-886X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory M. Cote","raw_affiliation_strings":["3Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014554706","display_name":"Thomas E. Stinchcombe","orcid":"https://orcid.org/0000-0002-3595-8011","observed_orcids":["https://orcid.org/0000-0002-3595-8011"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas E. Stinchcombe","raw_affiliation_strings":["4Duke Cancer Institute, Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Duke Cancer Institute, Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049294543","display_name":"Melissa Lynne Johnson","orcid":"https://orcid.org/0000-0001-9874-1314","observed_orcids":["https://orcid.org/0000-0001-9874-1314"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa L. Johnson","raw_affiliation_strings":["5Sarah Cannon Research Institute, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Sarah Cannon Research Institute, Nashville, TN;","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102709933","display_name":"Christopher T. Chen","orcid":"https://orcid.org/0000-0001-8962-3527","observed_orcids":["https://orcid.org/0000-0001-8962-3527","https://orcid.org/0000-0001-8911-0203","https://orcid.org/0000-0002-6527-7022"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher T. Chen","raw_affiliation_strings":["6Stanford University School of Medicine, Palo Alto, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Stanford University School of Medicine, Palo Alto, CA;","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088846258","display_name":"Siddhartha H. K. Devarakonda","orcid":"https://orcid.org/0000-0003-2693-3848","observed_orcids":["https://orcid.org/0000-0003-2693-3848"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siddhartha H. Devarakonda","raw_affiliation_strings":["7Washington University School of Medicine, St Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Washington University School of Medicine, St Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082563712","display_name":"Naisargee Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naisargee Shah","raw_affiliation_strings":["8Rain Therapeutics, Inc., Newark, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Rain Therapeutics, Inc., Newark, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100432902","display_name":"Feng Xu","orcid":"https://orcid.org/0000-0002-4670-3727","observed_orcids":["https://orcid.org/0000-0002-4670-3727","https://orcid.org/0009-0001-8046-8361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feng Xu","raw_affiliation_strings":["8Rain Therapeutics, Inc., Newark, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Rain Therapeutics, Inc., Newark, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034705456","display_name":"Robert Charles Doebele","orcid":"https://orcid.org/0000-0001-6728-6857","observed_orcids":["https://orcid.org/0000-0001-6728-6857"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert C. Doebele","raw_affiliation_strings":["8Rain Therapeutics, Inc., Newark, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Rain Therapeutics, Inc., Newark, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034595315","display_name":"Mrinal M. Gounder","orcid":"https://orcid.org/0000-0001-8468-0119","observed_orcids":["https://orcid.org/0000-0001-8468-0119"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mrinal M. Gounder","raw_affiliation_strings":["9Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I205783295"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"CT123","last_page":"CT123"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/milademetan","display_name":"milademetan","score":0.9750000238418579},{"id":"https://openalex.org/keywords/mdm2-inhibitors","display_name":"MDM2 inhibitors","score":0.8600000143051147},{"id":"https://openalex.org/keywords/mdm2-amplification","display_name":"MDM2 amplification","score":0.8989999890327454},{"id":"https://openalex.org/keywords/wild-type-p53","display_name":"wild-type p53","score":0.8560000061988831},{"id":"https://openalex.org/keywords/p53-restoration","display_name":"p53 restoration","score":0.7250000238418579},{"id":"https://openalex.org/keywords/liposarcoma","display_name":"liposarcoma","score":0.6269999742507935},{"id":"https://openalex.org/keywords/intimal-sarcoma","display_name":"intimal sarcoma","score":0.6869999766349792},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.6740000247955322},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.4580000042915344},{"id":"https://openalex.org/keywords/oral-targeted-therapy","display_name":"oral targeted therapy","score":0.4429999887943268}],"concepts":[{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.748044490814209},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5896487236022949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5357614755630493},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.5114011168479919},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5032405257225037},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3846967816352844},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.38214820623397827},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2957492768764496},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2909772992134094},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.20690545439720154},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0940929651260376}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-ct123","doi":"https://doi.org/10.1158/1538-7445.am2022-ct123","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-ct123","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.699999988079071}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4286295703","https://openalex.org/W4413100569","https://openalex.org/W4282965409","https://openalex.org/W4389227602","https://openalex.org/W4200383547","https://openalex.org/W4282963912","https://openalex.org/W4281705492","https://openalex.org/W4200593165","https://openalex.org/W2890084166","https://openalex.org/W4307910995"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Murine":[2],"double":[3],"minute":[4],"2":[5,396],"(MDM2)":[6],"is":[7,110,156,218,250,272,331,355],"a":[8,51,148,157,222,267],"potent":[9],"negative":[10],"regulator":[11],"of":[12,20,35,55,69,83,93,121,152,173,192,266,298,313,328,398,419],"the":[13,67,88,168,399,420],"tumor":[14,40,131,134,323],"suppressor":[15,41],"p53.":[16],"MDM2":[17,36,76,80,117,143,180,216,223,248,344,400],"induces":[18],"degradation":[19],"p53":[21,39],"and":[22,28,64,104,125,215,264,282,284,343,354,408],"promotes":[23],"tumorigenesis":[24],"in":[25,43,138,147,175,320,351,403],"solid":[26,58,94,177,204,413],"tumors,":[27],"preclinical":[29],"models":[30,128],"have":[31,338],"shown":[32],"that":[33,66,335],"inhibition":[34],"can":[37],"restore":[38],"activity":[42],"TP53-wild":[44,406],"type":[45,407],"(WT),":[46],"MDM2-amplified":[47,409],"tumors.":[48],"We":[49],"performed":[50],"mutual":[52],"exclusivity":[53],"analysis":[54],"patients":[56,141,187,330,337,404],"with":[57,74,142,179,194,231,246,405],"tumors":[59,95,178,205,241,414],"(n=42,125;":[60],"AACR":[61],"Project":[62],"GENIE)":[63],"found":[65],"frequency":[68],"co-occurring":[70],"TP53":[71,213,341],"mutations":[72],"decreased":[73],"increasing":[75],"copy":[77,81,144,224,345],"number.":[78],"An":[79,90],"number":[82,145,183,225,346],"12":[84,287],"was":[85,136],"chosen":[86],"as":[87,221],"threshold.":[89],"estimated":[91],"1.1%":[92],"meet":[96],"this":[97,108],"molecular":[98],"criteria,":[99],"excluding":[100],"glioblastomas,":[101],"de-differentiated":[102],"liposarcomas,":[103,233],"intimal":[105,234],"sarcomas":[106],"where":[107],"signature":[109],"enriched.":[111],"Milademetan":[112],"(RAIN-32),":[113],"an":[114,247],"oral,":[115],"selective":[116],"inhibitor,":[118],"inhibits":[119],"growth":[120,302],"TP53-WT/MDM2-amplified":[122],"cell":[123],"lines":[124],"patient-derived":[126],"xenograft":[127],"from":[129],"varying":[130],"types.":[132],"Furthermore,":[133],"regression":[135],"observed":[137],"3/3":[139],"non-liposarcoma":[140],">12":[146],"phase":[149,158,395],"1":[150],"trial":[151,164,349],"milademetan.":[153],"MANTRA-2":[154],"(RAIN-3202)":[155],"2,":[159],"multicenter,":[160],"single-arm,":[161],"open-label,":[162],"basket":[163],"designed":[165],"to":[166,207,333],"evaluate":[167],"efficacy":[169],"or":[170,202,227,236,411],"clinical":[171],"benefit":[172],"milademetan":[174,255,402],"TP53-WT":[176],"amplification":[181,217],"(copy":[182],"\u226512).":[184],"Methods:":[185],"Eligible":[186],"must":[188],"be":[189],"\u226518":[190],"years":[191],"age":[193],"histologically":[195],"and/or":[196,322],"cytologically":[197],"confirmed":[198,340],"locally":[199],"advanced,":[200],"incurable":[201],"metastatic":[203,412],"refractory":[206],"standard":[208],"therapy.":[209],"Local":[210],"testing":[211],"demonstrating":[212],"WT":[214,342],"required,":[219],"defined":[220],"\u226512":[226],"6-fold":[228],"increase.":[229],"Patients":[230,253],"well-differentiated/de-differentiated":[232],"sarcomas,":[235],"primary":[237],"central":[238],"nervous":[239],"system":[240],"are":[242],"excluded.":[243],"Prior":[244],"treatment":[245],"inhibitor":[249,401],"not":[251],"permitted.":[252],"receive":[254],"260":[256],"mg":[257],"orally":[258],"once":[259],"daily":[260],"on":[261],"Days":[262],"1-3":[263],"15-17":[265],"28-day":[268],"cycle.":[269],"Tumor":[270],"response":[271,292],"evaluated":[273],"by":[274],"RECIST":[275],"v1.1":[276],"at":[277],"Weeks":[278],"8,":[279],"16,":[280],"24,":[281],"32,":[283],"then":[285],"every":[286],"weeks.":[288],"Primary":[289],"endpoint:":[290],"objective":[291],"rate.":[293],"Secondary":[294],"endpoints":[295,317],"include:":[296,318],"duration":[297],"response;":[299],"progression-free":[300],"survival;":[301,309],"modulation":[303],"index;":[304],"disease":[305],"control":[306],"rate;":[307],"overall":[308],"safety;":[310],"health-related":[311],"quality":[312],"life":[314],"scores.":[315],"Exploratory":[316],"biomarkers":[319],"blood":[321],"tissue;":[324],"pharmacodynamics;":[325],"pharmacokinetics.":[326],"Enrollment":[327],"65":[329],"planned":[332],"ensure":[334],"57":[336],"centrally":[339],"\u226512.":[347],"The":[348],"opened":[350],"November":[352],"2021":[353],"actively":[356],"enrolling":[357],"patients.":[358],"ClinicalTrials.gov:":[359],"NCT05012397.":[360],"Citation":[361],"Format:":[362],"Ecaterina":[363],"I.":[364],"Dumbrava,":[365],"Glenn":[366],"J.":[367],"Hanna,":[368],"Gregory":[369],"M.":[370,392],"Cote,":[371],"Thomas":[372],"E.":[373],"Stinchcombe,":[374],"Melissa":[375],"L.":[376],"Johnson,":[377],"Christopher":[378],"T.":[379],"Chen,":[380],"Siddhartha":[381],"H.":[382],"Devarakonda,":[383],"Naisargee":[384],"Shah,":[385],"Feng":[386],"Xu,":[387],"Robert":[388],"C.":[389],"Doebele,":[390],"Mrinal":[391],"Gounder.":[393],"A":[394],"study":[397],"advanced":[410],"(MANTRA-2)":[415],"[abstract].":[416],"In:":[417],"Proceedings":[418],"American":[421],"Association":[422],"for":[423],"Cancer":[424,435],"Research":[425],"Annual":[426],"Meeting":[427],"2022;":[428],"2022":[429],"Apr":[430],"8-13.":[431],"Philadelphia":[432],"(PA):":[433],"AACR;":[434],"Res":[436],"2022;82(12_Suppl):Abstract":[437],"nr":[438],"CT123.":[439]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-06-16T00:00:00"}